Death Reporter 5 (DR5) expression has been reported stronger in cancer cells than in normal cells29 indicating chemotherapeutic agent that targeted to DR5 may have less cytotoxic effect in normal cells. The gene discussed is TNFRSF10B; the disease is cancer.